DDW 2022 Updates: IBS, Eosinophilic Esophagitis, and C difficile
Read updates on effective treatments for IBS, the effects of food allergies on proton pump inhibitor efficacy, and oral microbiome therapy for C difficile and more from DDW 2022.
Diagnosis & Disease Information
Irritable Bowel Syndrome: What Your Patients Need to Know
Irritable bowel syndrome is rarely serious, but is still an inconvenience and a painful disorder for patients who have it. For patients who have IBS or are concerned they may have it, how can you explain the basics of how it is detected and managed?
Assessing Symptoms, Blood, Stool Markers Best for Identifying Pediatric IBD
For pediatric patients with nonbloody diarrhea, evaluating symptoms plus blood and stool markers is the optimal test strategy for predicting IBD.
Risk for Severe COVID-19 Not Elevated in Patients with Inflammatory Bowel Disease
Patients with inflammatory bowel disease had a similar risk for and outcomes from coronavirus disease 2019 as those in the general population.
Microbiome-Based Therapy Looks Promising for Recurrent C difficile Infection
“These positive preliminary findings represent a major step forward towards bringing an innovative, non-antibiotic option to patients that may help restore their gut microbiome,” said Per Falk, Ferring’s President and Chief Science Officer.
Diarrhea in Patients With COVID-19 Suggests Possible Oral-Fecal Transmission Route
The fact that diarrhea is a symptom in the disease course of some patients with COVID-19 highlights the importance of adhering to preventative measures.
Recommendations Developed for Evaluating Chronic Diarrhea
AGA recommends fecal calprotectin, lactoferrin for screening for inflammatory bowel disease.
Rifaximin Beneficial for Abdominal Pain Symptoms in Irritable Bowel Syndrome With Diarrhea
Researchers evaluated the response of rifaximin therapy in patients with IBS-D with abdominal pain symptoms.
Uropathogenic E coli Infection Commonly Manifests As Traveler’s Diarrhea
After molecular testing, half of all travel-acquired ESBL-producing E coli strains qualified as pathogens, despite most being classified as extraintestinal pathogenic or uropathogenic.
Patient’s Diarrhea, Weight Loss Linked to Antihypertensive Med
A recently published report describes the case of a 59-year-old male patient who experienced olmesartan-associated enteropathy (OAE) and highlights the importance of performing thorough medication reviews.
- Loading...
Loading...
Next post in Gastroenterology Information Center
Loading... 
Loading...